Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19
Retrospective Evaluation of Electrocardiographic Findings of Right Ventricular Overload in Covid 19 Patients With Respiratory Distress
1 other identifier
observational
160
1 country
1
Brief Summary
In patients with coronavirus disease (COVID-19), severe dyspnea is the most dramatic complication.Severe respiratory difficulties may include electrocardiographic frontal QRS axis rightward shift (Rws) and clockwise rotation (Cwr). This study investigated the predictability of advanced lung tomography findings with QRS axis shift and rotation. This was a retrospective analysis of 160 patients.The patients were divided into two groups: normal oxygen saturation(SpO2) (NS; n = 80) and low SpO2(LS;n = 80).They were then divided into NS Rws (n = 37), NS leftward shift (Lws; n = 43), LS Rws (n = 40), and LS Lws (n = 40) according to electrocardiographic follow-up findings. These groups were compared in terms of electrocardiographic rotation (Cwr, counterclockwise rotation, or normal transition), tomographic stage (CO-RADS5(advanced)/CO-RADS1-4), electrocardiographic intervals, and laboratory findings
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2020
CompletedFirst Submitted
Initial submission to the registry
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedJanuary 6, 2021
January 1, 2021
3 months
January 4, 2021
January 5, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Differences in the electrocardiographic QRS axis shift(°),
Differences in the axis shift between the Rws and Lws groups in patients with NS /LS groups.
10-15 days
Differences in the electrocardiographic rotation
Differences in clockwise,counterclockwise,normal transition between the groups.
10-15 days
Differences in the CO-RADS5/CO-RADS1-4 ratio
Differences in the CO-RADS5/CO-RADS1-4 ratio between the groups.
10-15 days
Study Arms (2)
Group1:normal SpO2(NS,n = 80) and low SpO2(LS, n = 80).
Patients with normal oxygen saturation (SpO2; ≥ 90%) who did not receive oxygen therapy and patients with low SpO2(\<90%) who received nasal oxygen therapy were included in this study
Group2:Rightward axis shift(Rws) and Leftward axis shift (Lws)
Both groups were divided into two main subgroups:patients with Rws and patients with leftward shift(Lws) of the QRS axis.The patient numbers were as follows: NS Rws (n=37),NS Lws(n=43),LS Rws (n=40),andLS Lws (n=40)
Interventions
Based on electrocardiographic follow-up analyses,the two main groups were compared in terms of rotation condition (i.e., Cwr, normal transition, or CCwr), electrocardiographic intervals, and laboratory findings In our study,CO-RADS5 was considered an advanced tomographic finding(e.g., multifocal ground glass opacities with consolidation, vascular thickening,crazy paving pattern,mixed pattern),while CO-RADS1,2,3, and 4 were considered non-advanced tomographic findings.
Eligibility Criteria
Hospitalized patients with dyspnea and COVID-19
You may qualify if:
- Hospitalized patients with dyspnea and COVID-19
You may not qualify if:
- Patients who received positive pressurized oxygen therapy Patients who underwent mechanical ventilation, Atrial fibrillation Complete bundle branch block Significant arrhythmias(complete atrioventricular block, polymorphic ventricular tachycardia, and ventricular fibrillation), Wolff-Parkinson-White syndrome, supraventricular tachycardia Unclear QRS axis orientation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Şahbender Koç
Ankara, 06530, Turkey (Türkiye)
Related Publications (1)
Koc S, Bozkaya VO, Yikilgan AB. Electrocardiographic QRS axis shift, rotation and COVID-19. Niger J Clin Pract. 2022 Apr;25(4):415-424. doi: 10.4103/njcp.njcp_9_21.
PMID: 35439899DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Şahbender Koç
University of Health Sciences Ankara Keçiören Education Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardıologist
Study Record Dates
First Submitted
January 4, 2021
First Posted
January 6, 2021
Study Start
July 22, 2020
Primary Completion
October 15, 2020
Study Completion
November 5, 2020
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share